The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients

Diabetes and Metabolism

Volumn 38, Issue 4, 2012, Pages 291-297

  Halimi, J M ^a  

^a FHU SUPORT   (France)

Author keywords

Albuminuria; Chronic kidney disease; Diabetes; Epidemiology; Renin angiotensin system; Review

Indexed keywords

ALBUMIN;

ALBUMINURIA; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK ASSESSMENT;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EVIDENCE-BASED MEDICINE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; SENTINEL SURVEILLANCE;

EID: 84866744335     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2012.04.001     Document Type: Review

References (37)

1. Viberti G.C., Hill R.D., Jarrett R.J., Argyropoulos A., Mahmud U., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1:1430-1432.
2. Parving H.H., Oxenboll B., Svendsen P.A., Christiansen J.S., Andersen A.R. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol 1982, 100:550-555.
3. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984, 311:89-93.
4. Mathiesen E.R., Oxenbøll B., Johansen K., Svendsen P.A., Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984, 26:406-410.
5. Hasslacher C., Ritz E., Wahl P., Michael C. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 1989, 4:859-863.
6. Adler A.I., Stevens R.J., Manley S.E., Bilous R.W., Cull C.A., Holman R.R. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003, 63:225-232.
7. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., Holman R.R., UKPDS Study Group Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006, 55:1832-1839.
8. Perkins B.A., Ficociello L.H., Roshan B., Warram J.H., Krolewski A.S. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010, 77:57-64.
9. Perkins B.A., Ficociello L.H., Ostrander B.E., Silva K.H., Weinberg J., Warram J.H., et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007, 18:1353-1361.
10. Molitch M.E., Steffes M., Sun W., Rutledge B., Cleary P., de Boer I.H., et al. Epidemiology of Diabetes Interventions and Complications Study Group. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010, 33:1536-1543.
11. Rigalleau V., Lasseur C., Raffaitin C., Beauvieux M.C., Barthe N., Chauveau P., et al. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Diabetes Care 2007, 30:2034-2039.
12. Hellemons M.E., Persson F., Bakker S.J., Rossing P., Parving H.H., De Zeeuw D., et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011, 34:2078-2083.
13. Thomsen O.F., Andersen A.R., Christiansen J.S., Deckert T. Renal changes in long-term type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material. Diabetologia 1984, 26:361-365.
14. Fioretto P., Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007, 27:195-207.
15. Caramori M.L., Fioretto P., Mauer M. Low glomerular filtration rate in normoalbuminuric Type 1 diabetic patients. An indicator of more advanced glomerular lesions. Diabetes 2003, 52:1036-1040.
16. Tervaert T.W., Mooyaart A.L., Amann K., Cohen A.H., Cook H.T., Drachenberg C.B., et al. Renal Pathology Society Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010, 21:556-563.
17. Halimi J.M., Sautenet B., Gatault P., Roland M., Giraudeau B. Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?. Fundam Clin Pharmacol 2011, doi:10.1111/j.1472-8206. 2011.00965.x.
18. van den Heuvel M., Batenburg W.W., Jainandunsing S., Garrelds I.M., van Gool J.M., Feelders R.A., et al. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J Hypertens 2011, 29:2147-2155.
19. Tabaei B.P., Al-Kassab A.S., Ilag L.L., Zawacki C.M., Herman W.H. Does microalbuminuria predict diabetic nephropathy?. Diabetes Care 2001, 24:1560-1566.
20. Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., Krolewski A.S. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003, 348:2285-2293.
21. Hovind P, Tarnow L, Rossing P, Jensen B.R, Graae M, Torp I, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004. doi:10.1136/bmj.38070.450891.FE, May 8, 2012.
22. Gaede P., Tarnow L., Vedel P., Parving H.H., Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 2004, 19:2784-2788.
23. Araki S., Haneda M., Sugimoto T., Isono M., Isshiki K., Kashiwagi A., et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005, 54:2983-2987.
24. Steinke J.M., Sinaiko A.R., Kramer M.S., Suissa S., Chavers B.M., Mauer M. International Diabetic Nephopathy Study Group. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 2005, 54:2164-2171.
25. Yamada T., Komatsu M., Komiya I., Miyahara Y., Shima Y., Matsuzaki M., et al. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study. Diabetes Care 2005, 28:2733-2738.
26. Ficociello L.H., Perkins B.A., Silva K.H., Finkelstein D.M., Ignatowska-Switalska H., Gaciong Z., et al. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol 2007, 2:461-469.
27. Kramer H.J., Nuyen Q.D., Curhan G., Hsu C.Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with Type 2 diabetes mellitus. JAMA 2003, 289:3273-3277.
28. McIsaac R.J., Tsalamandris C., Panagiotopoulos S., Smith T.J., MacNeill K.J., Jerums G. Nonalbuminuric renal insufficiency in Type 2 diabetes. Diabetes Care 2004, 27:195-200.
29. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., Holman R.R., for the UKPDS Study Group Risk Factors for Renal Dysfunction in Type 2 Diabetes. U. K. Prospective Diabetes Study. Diabetes 2006, 55:1832-1839.
30. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. for the DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney International 2006, 69:2057-2063.
31. Yokoyama H., Sone H., Oishi M., Kawai K., Fukumoto Y., Kobayashi M., et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009, 24:1212-1219.
32. Afghahi H., Cederholm J., Eliasson B., Zethelius B., Gudbjörnsdottir B., Hadimeri H., et al. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes-the Swedish National Diabetes Register (NDR). Nephrol Dial Transplant 2011, 26:1236-1243.
33. Penno G., Solini A., Bonora E., Fondelli C., Orsi E., Zerbini G., et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011, 29:1802-1809.
34. Thomas M.C., McIsaac R.J., Jerums G., Weekes A., Moran J., Shaw J.E., et al. Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment coexisting with NIDDM [NEFRON] 11). Diabetes Care 2009, 32:1497-1502.
35. Newman D.J., Mattock M.B., Dawnay A.B.S., Kerry S., McGuire A., Yaqoob M., et al. Systematic review on urine albumin testing for early detection of diabetic Complications. Health Technology Assessment 2005, 9:1-189.
36. MacIsaac R.J., Panagiotopoulos S., McNeil K.J., Smith T.J., Tsalamandris C., Hao H., et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?. Diabetes Care 2006, 29:1560-1566.
37. de Boer I.H., Rue T.C., Hall Y.N., Heagerty P.J., Weiss N.S., Himmelfarb J. Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States. JAMA 2011, 305:2532-2539.